Skip to main content

Table 1 Clinical characteristics and dialysis-related data of patients (n = 191)

From: Dialysis recovery time: associated factors and its association with quality of life of hemodialysis patients

Parameter

Overall

 

No (%), Mean ± SD or Median (Min.-Max.)

Age (years)

47.0 (18.0–80.0)

Sex

 Male

112 (58.6)

 Female

79 (41.4)

Vintage of HD (years)

5.0 (0.25–31.0)

Smokers

36 (18.8)

MAP (mm/Hg)

 - Pre session

98.30 (50.0–153.0)

 - Post session

93.0 (37.0–163.0)

Main comorbidities

 - Hypertension

106 (55.5)

 - HCV

37 (19.4)

 - DM

25 (13.1)

 - IHD

21 (11)

 - COPD

12 (6.3)

 - HF

8 (4.2)

Dialysis modality

 HD

181 (94.8)

 HDF

10 (5.2)

HD schedule

 

 Morning

98 (51.3)

 Afternoon

78 (40.8)

 Evening

15 (7.9)

Vascular access

 -AV fistula

165 (86.4)

 -Cuffed catheter

24 (12.6)

 -Graft

2 (10)

HD prescription

 High flux dialyzer

190 (99.5)

 Dialyzer surface area (m2)

1.80 (1.70–2.20)

 Blood flow rate (ml/min)

300.0 (220.0–450.0)

 Session duration (hr.)

4.0 (3.0–5.0)

 UF volume (ml/session)

3000.0 (0.0–6500.0)

 UF rate (ml/hr.)

750.0 (0.0–1625.0)

 Dialysate temperature (°c)

36.50 (35.0–37.20)

 Dialysate Na (mmol)

140.0 (130.0–143.0)

 Dialysate flow (ml/hr)

650.0 (400.0–800.0)

 KT/V Daugridas

1.32 (0.42–2.14)

 K (mEq/L)

5.40 (2.30–7.80)

 Na (mEq/L)

133.0 (121.0–141.0)

 TIBC (mcg/dl)

230.0 (91.0–481.0)

 Hemoglobin (g/dl)

9.83 ± 1.57

 Serum albumin (g/dl)

3.90 (2.40–5.0)

 Serum calcium (mg/dl)

9.0 (6.0–12.10)

 Serum phosphorus (mg/dl)

5.64 ± 1.46

 Serum PTH (pg/ml)

355.0 (1.20–3850.0)

 CRP (mg/l)

9.0 (1.0–208.70)

  1. Normally quantitative data was expressed as Mean ± standard deviation (SD) while not normally quantitative data was expressed as Median (Min.–Max.), or absolute numbers as appropriate
  2. AV fistula arterio-venous fistula, CRP C reactive protein, COPD chronic obstructive lung disease, HCV hepatitis C virus, DM diabetes mellitus, HD hemodialysis, HDF hemodiafiltration, Kt/V measuring dialysis adequacy, HF heart failure, IHD ischemic heart disease, MAP mean arterial pressure, PTH parathyroid hormone, SGPT serum glutamic pyruvic transaminase, TIBC total iron binding capacity, UF ultrafiltration